Company Active LTD

Company profile

Orthonika Limited

Total Meniscus Replacement for the Knee | Orthonika

Orthonika is developing the Total Meniscus Replacement, a unique entirely anatomical replacement for the meniscus of the knee

CRN
09360214
Founded
2014
Age
11

Overview

Legal name
ORTHONIKA LIMITED
Region
Unknown
Registered address
2ND FLOOR
168 SHOREDITCH HIGH STREET
LONDON
UNITED KINGDOM
E1 6RA
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
7

Company events

Reference milestones and recent Companies House filing stream events.

7 events
14 Jan
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

31 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

14 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzOTMxNjY4NGFkaXF6a2N4

Published 14 Oct 2024 09:51

14 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzOTMxNjMxOGFkaXF6a2N4

Published 14 Oct 2024 09:45

18 Dec
2014

Incorporated

Inception

Company registered at Companies House

Public funding

6 awards
First funded
2017
Funded years
2017, 2019, 2022, 2023, 2025
Age at first award
2 years

Projects

2025 Collaborative R&D Lead participant

Novel scaffold structure for meniscocapsular tissue attachment and ingrowth for performance enhancement of a synthetic total meniscus replacement

1 Jun 2025 to 31 May 2026

Awarded
£321,170
Total cost £458,814

Over 4 million people annually in the UK are affected by pain and immobility caused by a deficient meniscus in the knee, costing the equivalent of 1% GNP. This includes those suffering from age-related osteoarthritis as well as meniscal damage from accidents or sports injuries. Treatment options have been limited by challenges in developing load-bearing m...

2023 Collaborative R&D Lead participant

Accelerating pre-clinical development and translation of a novel total meniscus replacement towards first in human studies

1 May 2023 to 30 Apr 2025

Awarded
£936,937
Total cost £1,338,482

Public description Over 4 million people annually in the UK are affected by pain and immobility caused by a deficient meniscus in the knee, costing the equivalent of 1% GNP. This includes those suffering from age-related osteoarthritis as well as meniscal damage from accidents or sports injuries. Treatment options have been limited by challenges in develo...

2022 Collaborative R&D Lead participant

Manufacturing development of an orthopaedic knee implant for total meniscus replacement incorporating a novel load-bearing hydrogel

1 Mar 2022 to 31 Aug 2023

Awarded
£342,322
Total cost £489,031

Over 4m people annually in the UK are affected by pain and immobility caused by a deficient meniscus, costing the equivalent of 1% GNP (NHS Business Plan 2017). The problem goes beyond age-related degenerative diseases and includes accidents/sports injuries in patients of any age. Technological challenges in developing load-bearing materials with suitable...

2019 Collaborative R&D Lead participant

Novel manufacturing process and material development for an innovative load bearing hydrogel for use in orthopedic implants

1 Oct 2019 to 31 Mar 2021

Awarded
£323,772
Total cost £462,532

Orthonika, an SME spin-out from Imperial College London, has developed novel load-bearing polymer materials for use in orthopaedic implants and is now planning to transfer manufacturing from the bench into a production environment. These exciting materials have the potential to address key healthcare challenges associated with soft tissue injuries such as...

2017 Feasibility Studies Lead participant

Surface engineering for improved performance in orthopedic implants

1 Jul 2017 to 30 Jun 2018

Awarded
£101,529
Total cost £145,058

Orthonika was established to develop an orthopaedic implant for total meniscus replacement in the human knee. This is a demanding biological environment requiring sophisticated coatings. The company has combined an innovative manufacturing process with engineering and clinical input to fabricate a textile-reinforced hydrogel substrate for a synthetic meni...

2017 Collaborative R&D Lead participant

Innovative Textile Reinforced Anatomical Total Meniscus Replacement for the Knee Joint

1 Feb 2017 to 30 Apr 2018

Awarded
£261,090
Total cost £372,985

Given the critical role the menisci play in the knee joint in terms of load transmission and joint stability, Meniscus injury is the most frequent orthopaedic surgical intervention with meniscus -related operations accounting for up to 50% of all knee surgeries. Despite this prevalence, for severely damaged menisci today’s standard of care is still partia...

Product types

Collaborative R&D Feasibility Studies